DaVita Inc. ($DVA) Stock Forecast: Up 2.2% Today

What is DaVita Inc.?

DaVita Inc. is a healthcare company specializing in kidney dialysis and lab services. The company operates domestically and internationally, with a recent strong bullish movement in the stock market.

Why is DaVita Inc. going up?

DVA stock is up 2.2% on Dec 10, 2025 15:50

• Despite DaVita Inc. falling short of recent EPS expectations and receiving cautious ratings from analysts, various institutional investors have notably increased their stakes in the company, including L2 Asset Management LLC, Norges Bank, Arrowstreet Capital Limited Partnership, Quantbot Technologies LP, and Edgestream Partners L.P.
• The stock's positive movement could be attributed to these institutional investments, indicating confidence in DaVita's long-term prospects despite recent performance challenges.
• Market attention appears to be shifting towards DaVita's future potential, as demonstrated by increased institutional ownership, rather than solely focusing on recent financial results and analyst outlooks.
• Anticipation surrounding the company's FY2025 guidance, which analysts are predicting DaVita will meet, may have also fueled positive sentiment and stock movement.

DVA Price Chart

DVA Technical Analysis

DVA News

L2 Asset Management LLC Grows Position in DaVita Inc. $DVA

L2 Asset Management LLC significantly increased its stake in DaVita Inc. (NYSE:DVA) by 742.2% in the second quarter, now holding 29,528 shares valued at $4.21 million. This move aligns with other institutional investors, collectively owning about 90.1% of the shares, despite the company missing recent EPS expectations and analysts maintaining a cautious "Reduce" rating with a $148 target. DaVita's stock performance reflects this caution, trading at $117.41 and analysts anticipating 10.76 EPS for the current year.

https://www.marketbeat.com/instant-alerts/filing-l2-asset-management-llc-grows-position-in-davita-inc-dva-2025-12-08/

Norges Bank Makes New Investment in DaVita Inc. $DVA

Norges Bank has acquired a new position in DaVita Inc. (NYSE:DVA) during the second quarter, purchasing 231,565 shares valued at approximately $32.99 million. This makes Norges Bank the owner of 0.32% of DaVita's stock. Other institutional investors have also modified their holdings in the company, which recently reported Q3 earnings per share of $2.51, missing analyst estimates.

https://www.marketbeat.com/instant-alerts/filing-norges-bank-makes-new-investment-in-davita-inc-dva-2025-12-08/

DaVita Inc. $DVA Shares Purchased by Arrowstreet Capital Limited Partnership

Arrowstreet Capital Limited Partnership significantly increased its stake in DaVita Inc. (NYSE:DVA) by 132.1% in the second quarter, now owning 264,084 shares valued at $37.62 million. Other institutional investors have also adjusted their holdings, with 90.12% of the stock owned by institutional investors and hedge funds. Analysts currently have a "Reduce" consensus rating with an average price target of $148.00, following recent earnings that missed expectations.

https://www.marketbeat.com/instant-alerts/filing-davita-inc-dva-shares-purchased-by-arrowstreet-capital-limited-partnership-2025-12-06/

Quantbot Technologies LP Acquires 50,040 Shares of DaVita Inc. $DVA

Quantbot Technologies LP significantly increased its stake in DaVita Inc. (NYSE:DVA) by 1,071.3% in the second quarter, acquiring an additional 50,040 shares, bringing its total to 54,711 shares valued at $7.79 million. This increase comes despite a weakening analyst sentiment, with many firms downgrading the stock and setting a consensus price target of $148.00 against the current trading price of around $119. DaVita missed Q3 EPS expectations but provided FY2025 guidance that analysts anticipate to be met.

https://www.marketbeat.com/instant-alerts/filing-quantbot-technologies-lp-acquires-50040-shares-of-davita-inc-dva-2025-12-03/

Edgestream Partners L.P. Invests $6.38 Million in DaVita Inc. $DVA

Edgestream Partners L.P. has acquired a new stake of 44,754 shares in DaVita Inc. (NYSE:DVA), valued at approximately $6.38 million, representing 0.06% ownership. This comes as DaVita recently missed quarterly earnings expectations and received multiple price target cuts, leading to a consensus "Reduce" rating from analysts. The stock is currently trading near $119, with a market capitalization of $8.41 billion.

https://www.marketbeat.com/instant-alerts/filing-edgestream-partners-lp-invests-638-million-in-davita-inc-dva-2025-12-03/

Trending Today

Marathon Digital Holdings Inc. ($MARA) Stock Forecast: Down 5.0% Today

KLA-Tencor Corporation ($KLAC) Stock Forecast: Down 2.6% Today

Dow Jones Industrial Average ($INDU) Index Forecast: Down 0.6% Today

NASDAQ-100 ($NDX) Index Forecast: Down 1.0% Today

Monolithic Power Systems Inc. ($MPWR) Stock Forecast: Down 3.5% Today

Analog Devices Inc. ($ADI) Stock Forecast: Down 2.2% Today

Caterpillar Inc. ($CAT) Stock Forecast: Down 4.9% Today

Oracle Corporation ($ORCL) Stock Forecast: Down 5.6% Today

Broadcom Inc. ($AVGO) Stock Forecast: Down 5.2% Today

General Mills Inc. ($GIS) Stock Forecast: Up 3.8% Today

DaVita Inc. Price History

30.09.2025 - DVA Stock was down 5.2%

• DaVita HealthCare (DVA) reported Q3 earnings below estimates, showing a negative surprise in earnings but a slight positive surprise in revenue.
• Despite efforts to enhance performance through technology upgrades and cost control, challenges like high missed treatments and low volume growth may have negatively impacted the stock.
• Investor concerns about the company's ability to address these operational issues and achieve sustainable growth may have contributed to today's bearish stock movement.

13.04.2025 - DVA Stock was down 5.8%

• Despite the bullish market sentiment, DaVita (DVA) faced significant bearish movement.
• The focus on Fox Corporation's earnings report could have detracted attention from DaVita's performance, prompting investors to realign their interests.
• Factors internal to DaVita or external circumstances not specified led to a negative market response.
• Despite favorable market conditions, investor wariness about DaVita's future prospects resulted in a stock sell-off.

31.09.2025 - DVA Stock was down 6.2%

• Post its Q3 earnings release, DaVita's stock witnessed a downward trend.
• The company showed revenue growth, but its earnings fell short of expectations, resulting in a decline in stock prices.
• Concerns about financial performance arise from narrower margins and earnings below estimates.
• Investors seemed dissatisfied with the earnings miss, overshadowing positive elements such as revenue growth and cost management endeavors.

14.00.2025 - DVA Stock was up 5.3%

• DVA displayed a robust bullish trend despite the market drop.
• This positive momentum may stem from solid financial performance or favorable developments in the healthcare sector.
• Investors seem to trust DaVita's capacity to manage market changes effectively and provide steady outcomes.
• The upward movement in DVA might reflect investor confidence in the company's future outlook and expansion opportunities in the healthcare field.

14.01.2025 - DVA Stock was down 13.1%

• DaVita's shares plunged over 10% in pre-market trading after Berkshire Hathaway trimmed its stake in the company, leading to investor concerns and selling pressure.
• The weak outlook for 2025 issued by DaVita, citing rising care costs and supply challenges, further contributed to the bearish sentiment surrounding the stock.
• Despite beating Q4 earnings and revenue estimates, the market reaction was overshadowed by Berkshire's sell-off and the cautious guidance provided by DaVita for the upcoming year.
• The combination of Berkshire's share reduction, disappointing future outlook, and ongoing industry challenges likely fueled the significant bearish movement in DaVita's stock price today.

22.06.2025 - DVA Stock was up 5.0%

• DVA showed a strong bullish movement, closing at $140.53, marking a 2.01% increase from the previous trading day despite the overall market downturn.
• Market sentiment towards DVA appears positive, potentially fueled by expectations of surpassing earnings estimates in the upcoming quarterly report, building on the company's track record.
• Investor optimism regarding DVA's future performance could be driving increased buying activity and pushing the stock price up.
• The uptick in DVA's performance may also be influenced by internal developments or positive sentiments in the market that have enhanced investor confidence in the stock.

06.07.2025 - DVA Stock was down 7.4%

• Despite DaVita HealthCare (DVA) beating earnings and revenue estimates in Q2, the stock saw a significant bearish movement.
• The larger fall in DVA compared to the overall market indicates specific factors affecting the company's stock price.
• The uncertainty surrounding PD supply issues may have contributed to the bearish trend in DVA's stock.
• Investors might be concerned about the potential impact of these supply issues on DaVita's future growth prospects, leading to the negative market movement.

06.07.2025 - DVA Stock was down 7.8%

• Despite strong second-quarter 2025 results, including surpassing earnings and revenue expectations and a rise in gross margin from core operations, DaVita HealthCare (DVA) faced significant bearish movement.
• There may be concerns about future growth, particularly related to uncertainties surrounding PD supply issues that could affect the company's performance.
• Investors might have anticipated even better outcomes or guidance for the future, which led to profit-taking and a decrease in the stock price despite positive financial results.
• The decline in DaVita's stock price could also be influenced by general market trends and challenges specific to the healthcare sector, resulting in a larger drop for DaVita compared to the overall market.

10.11.2025 - DVA Stock was up 2.2%

• Despite DaVita Inc. falling short of recent EPS expectations and receiving cautious ratings from analysts, various institutional investors have notably increased their stakes in the company, including L2 Asset Management LLC, Norges Bank, Arrowstreet Capital Limited Partnership, Quantbot Technologies LP, and Edgestream Partners L.P.
• The stock's positive movement could be attributed to these institutional investments, indicating confidence in DaVita's long-term prospects despite recent performance challenges.
• Market attention appears to be shifting towards DaVita's future potential, as demonstrated by increased institutional ownership, rather than solely focusing on recent financial results and analyst outlooks.
• Anticipation surrounding the company's FY2025 guidance, which analysts are predicting DaVita will meet, may have also fueled positive sentiment and stock movement.

17.02.2025 - DVA Stock was up 5.2%

• Following a larger decline than the wider market in the prior trading session, DaVita HealthCare (DVA) staged a robust recovery today, suggesting a resurgence in investor confidence.
• The positive movement in the stock may be linked to factors such as strong financial performance, new business collaborations, or favorable developments within the healthcare field.
• Investors responded favorably to potential avenues for growth or strategic plans revealed by DaVita HealthCare, propelling the stock price upwards.
• The uptick in DVA's performance could also be ascribed to broader market sentiments, with investors showing interest in healthcare stocks amidst uncertainties in the overall market.

14.01.2025 - DVA Stock was down 10.5%

• Despite DaVita's strong performance in Q4 and improved margins, the stock faced a bearish trend, possibly hinting at elevated market expectations.
• The company's cautious future outlook, along with escalating care expenses, contributed to the unsatisfactory guidance that impacted the stock negatively.
• The decision of a major shareholder to offload some DaVita shares, as part of a predetermined arrangement, added to the selling pressure on the stock.
• Factors like reduced holdings by the major shareholder, weaker projections for 2025, and the market's response to the financial results and revenue forecasts likely instigated the notable decline in DaVita's stock value today.

29.09.2025 - DVA Stock was down 1.9%

• Despite potential benefits from technology upgrades and cost control, DVA experienced a strong bearish movement.
• The high number of missed treatments and low volume growth likely impacted DVA's performance negatively.
• Investors may have reacted to these challenges by selling off DVA shares, leading to the bearish market movement today.